Recruiting
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy
NCT06174220
- Conditions
- Arrhythmias, Cardiac, Arrhythmogenic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, +14 more
- Locations
-
- University of Calgary Calgary, Alberta, Canada
- University of British Columbia Vancouver, British Columbia, Canada
- Victoria Cardiac Arrhythmia Trials Inc. Victoria, British Columbia, Canada
- NL Health Services St. John's, Newfoundland and Labrador, Canada